Yao Pharma stands to receive further development, regulatory, and commercial milestone payments potentially reaching up to $1.93 billion , in addition to tiered royalties on net sales
By suppressing glucagon after meals, GLP-1 removes another driver of high blood sugar
Individual results vary, but outcomes are clinically predictable with proper monitoring, lifestyle support, and attentive follow up
Similarly, Rybelsus has relatively low oral bioavailability and requires very specific conditions for absorption: it must be taken with no more than 120ml of water, on an empty stomach, with no food, drink, or other oral medications for at least 30 minutes afterwards
5 Secondary polycythemia is triggered by other medical conditions, medications, or environmental factors